Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet.

Allosteric coupling Molecular dynamics simulations N-SH2 domain NMR spectroscopy Protein flexibility SHP2 phosphatase

Journal

Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369

Informations de publication

Date de publication:
Dec 2024
Historique:
received: 15 12 2023
revised: 26 02 2024
accepted: 26 02 2024
medline: 21 3 2024
pubmed: 21 3 2024
entrez: 21 3 2024
Statut: epublish

Résumé

SHP2 is a tyrosine phosphatase that plays a regulatory role in multiple intracellular signaling cascades and is known to be oncogenic in certain contexts. In the absence of effectors, SHP2 adopts an autoinhibited conformation with its N-SH2 domain blocking the active site. Given the key role of N-SH2 in regulating SHP2, this domain has been extensively studied, often by X-ray crystallography. Using a combination of structural analyses and molecular dynamics (MD) simulations we show that the crystallographic environment can significantly influence the structure of the isolated N-SH2 domain, resulting in misleading interpretations. As an orthogonal method to X-ray crystallography, we use a combination of NMR spectroscopy and MD simulations to accurately determine the conformation of apo N-SH2 in solution. In contrast to earlier reports based on crystallographic data, our results indicate that apo N-SH2 in solution primarily adopts a conformation with a fully zipped central β-sheet, and that partial unzipping of this β-sheet is promoted by binding of either phosphopeptides or even phosphate/sulfate ions.

Identifiants

pubmed: 38510972
doi: 10.1016/j.csbj.2024.02.023
pii: S2001-0370(24)00047-3
pmc: PMC10951427
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1169-1180

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michelangelo Marasco (M)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

John Kirkpatrick (J)

School of Biosciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, UK.

Teresa Carlomagno (T)

School of Biosciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, UK.
Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, B15 2TT Birmingham, UK.

Jochen S Hub (JS)

Theoretical Physics and Center for Biophysics, Saarland University, 66123 Saarbrücken, Germany.

Massimiliano Anselmi (M)

Theoretical Physics and Center for Biophysics, Saarland University, 66123 Saarbrücken, Germany.

Classifications MeSH